We are live on ! Find out more
BBLGW

Bone Biologics Corp Warrants
BBLGW

3 hedge funds and large institutions have $570K invested in Bone Biologics Corp Warrants in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,170% more capital invested

Capital invested by funds: $44.9K → $570K (+$525K)

200% more funds holding

Funds holding: 1 → 3 (+2)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

5.9% more ownership

Funds ownership: 0.37% → 6.27% (+5.9%)

Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$364K
2
Bank of America
Bank of America
North Carolina
+$1.1K
3
CS
Clear Street
New York
+$1.1K

Top Sellers

Rank Fund Capital Flow
1
MG
Marex Group
-$44.9K

BBLGW Hedge Fund Activity: Q1 2024 in Review

3 of the 6,961 institutional investors tracked by Wall St. Rank reported a position in Bone Biologics Corp Warrants (BBLGW) for Q1 2024, worth a combined $570K — up 1,170% from $44.9K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BBLGW positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $364K. The largest seller was Marex Group, exiting entirely with an estimated $44.9K sold.

  • 3 institutional investors held Bone Biologics Corp Warrants (BBLGW) as of Q1 2024, up from 1 in Q4 2023.
  • Funds reported $570K of Bone Biologics Corp Warrants stock for Q1 2024, up 1,170% quarter-over-quarter.
  • 3 funds opened new Bone Biologics Corp Warrants positions in Q1 2024 and 1 closed out, a net change of +2 holders.
  • The largest Bone Biologics Corp Warrants buyer in Q1 2024 was Citadel Advisors, an estimated $364K added.
  • The largest Bone Biologics Corp Warrants seller in Q1 2024 was Marex Group, an estimated $44.9K sold.

Based on aggregated 13F filings for Q1 2024.